PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Scientists identify a new target for Alzheimer's disease

2010-09-22
(Press-News.org) (CHICAGO) – Neurological researchers at Rush University Medical Center have found a new therapeutic target that can potentially lead to a new way to prevent the progression of Alzheimer's disease. The target called neutral sphingomyelinase (N-SMase) is a protein that when activated, can cause a chain of reactions in the cell leading to neuronal death and memory loss.

Results from the study funded by the National Institutes of Health and the Alzheimer's Association will be published in the September 22 issue of the Journal of Neuroscience.

"There are multiple, neurotoxic, disease-causing pathways that converge on the neutral sphingomyelinase that can cause neuronal loss in the brain of an Alzheimer's patient," said Kalipada Pahan, PhD, neurological researcher and lead investigator at Rush. "If we can stop the activation of the neutral sphingomylinase, we may be able to stop memory loss and the progression of Alzheimer's disease."

In the brain of a patient with Alzheimer's disease, two abnormal structures called plaques and tangles are prime suspects in damaging and killing nerve cells. While neurons die, other brain cells like astroglia and microglia do not die. These cells become activated and glial cell activation plays a key role in the destruction of neurons. However, the molecular mechanisms by which activated glial cells can kill neurons have been poorly understood until now.

Beta-amyloid, which is a protein fragment deposited in the brains of patients who have Alzheimer's disease, causes the activation of glial cells. Neuritic plaques are mainly composed of aggregates of beta-amyloid. When healthy nerve cells in the brain are exposed to beta-amyloid, they exhibit a number of pathological changes that are characteristic of Alzheimer's pathology.

Researchers at Rush were able to determine that the neutral sphingomyelinase is triggered by the activated brain cells and beta-amyloid. However, when the neutral sphingomyelinase was inhibited by using a small molecule inhibitor and a chemical inhibitor, the activated brain cells and beta amyloid were unable to kill neurons.

Experts tested the two inhibitors using human brain cells in a mouse model and a cell culture model.

"Understanding how the disease process works is important in identifying effective approaches to protect the brain and stop the progression of Alzheimer's disease," said Pahan. "The results of this study are very promising and our next step is to translate these findings to the clinic."

"If we can develop and test a clinical medication that can target the neutral sphingomyelinase, we may be able to halt memory loss in Alzheimer's disease patients," said Pahan.

Alzheimer's disease is an irreversible, progressive brain disease that slowly destroys memory and thinking skills, and eventually even the ability to carry out the simplest tasks. In most people with Alzheimer's, symptoms first appear after age 60.Alzheimer's disease is the most common cause of dementia among older people. Alzheimer's disease affects as many as 5.3 million Americans.

INFORMATION:

Kalipada Pahan, PhD, is the Floyd Davis Professor of Neurology at Rush University Medical Center.

END



ELSE PRESS RELEASES FROM THIS DATE:

New study indicates children and parents want science assessment for 11-year-olds

2010-09-22
At a time when new transfer arrangements mean children in Northern Ireland will no longer be formally assessed in science at age 11, researchers at Queen's University have found overwhelming support for science assessment in primary schools in England and Wales. The study, which was conducted by researchers at Queen's School of Education on behalf of the Wellcome Trust, is the first study to look at the attitudes and concerns of children and parents on the way science is assessed in primary schools in England and Wales. It is hoped the findings will be used to inform ...

OHSU research suggests compound administered during some bone marrow transplants elevates risks

2010-09-22
PORTLAND, Ore - Research conducted at Oregon Health & Science University's Vaccine and Gene Therapy Institute may spur debate about the risks associated with administering a specific compound in some forms of bone-marrow transplantation. The research is published in the current edition of Cell Host and Microbe. The VGTI research team, led by institute director Jay Nelson, Ph.D., studies human cytomegalovirus, a virus that may infect up to 80 percent of the American population. The exact percentage of infected citizens is unknown due to the fact that the virus causes minor ...

Targeted therapy triggers complex mechanism of resistance

2010-09-22
Washington, DC – In order for targeted therapies against cancer to be effective, scientists need to understand upfront what related proteins in a signaling "network" makes a cancer cell resistant to a drug and selectively target them as well, say researchers at Georgetown Lombardi Comprehensive Cancer Center and Fox Chase Cancer Center. In the September 21 issue of Science Signaling, the investigators discuss how cancer cells activate a network of pro-growth proteins that can bypass a molecule being therapeutically targeted. The researchers specifically found that many ...

The Joy of sets: For ants and trees, multiple partners are a boon

2010-09-22
GAINESVILLE, Fla. — In the complex world of ant-plant partnerships, serial monogamy can help trees maximize their evolutionary fitness, a new University of Florida study shows. Trees that sequentially partner with multi-species sets of ants produce more offspring than trees that maintain a lifelong association with any single ant — even when those sets include ant species that appear to harm the tree, said Todd Palmer, a UF biology professor. The study has broad implications because many of the world's ecosystems rely on cooperative partnerships between species, Palmer ...

Avoid swimming in interplanetary lakes

2010-09-22
Titan, one of Saturn's moons, is the only moon in the solar system with an atmosphere ― ten times denser than the atmosphere of Earth. Five years ago, the Cassini–Huygens mission to Saturn, a collaboration between the European Space Agency and NASA, sent a probe through Titan's atmosphere, revealing that Titan is home to a landscape that includes hills, valleys and most notably lakes. A researcher involved with the mission, Prof. Akiva Bar-Nun of Tel Aviv University's Department of Geophysics and Planetary Sciences, has now determined the composition of these lakes. ...

Universal, primordial magnetic fields discovered in deep space by UCLA, Caltech physicists

2010-09-22
Scientists from the California Institute of Technology and UCLA have discovered evidence of "universal ubiquitous magnetic fields" that have permeated deep space between galaxies since the time of the Big Bang. Caltech physicist Shin'ichiro Ando and Alexander Kusenko, a professor of physics and astronomy at UCLA, report the discovery in a paper to be published in an upcoming issue of Astrophysical Journal Letters; the research is currently available online. Ando and Kusenko studied images of the most powerful objects in the universe — supermassive black holes that ...

Spare the rod, spoil the child?

2010-09-22
Grabbing a child firmly by the arm, yelling and repeatedly punishing him or her may not be without long-terms risks, according to researchers from the Université de Montréal. They are studying how this harsh parenting can impair the emotional development of a child, possibly leading to anxiety disorders such as social phobia, separation anxiety and panic attacks. "Several studies have shown that coercive parenting practices are linked to anxiety," says Françoise Maheu a professor at the Université de Montréal's Department of Psychiatry and lead investigator of the study. ...

'Synthetic lethality' strategy improves molecularly targeted cancer therapy

2010-09-22
PHILADELPHIA (September 21, 2010)—Molecularly targeted therapies can reduce tumors rapidly. However, not all tumors respond to the drugs, and even those that do often develop resistance over time. Looking for a way to combat the problem of resistance, researchers at Fox Chase Cancer Center hypothesized that hitting already weakened cancer cells with a second targeted agent could kill them—but only if it was the right second agent. One well-validated molecular target for anti-cancer drugs is the epidermal growth factor receptor, or EGFR. Using a novel screening approach, ...

Results of the placement of multiple endoscopic stents for postoperative biliary strictures remains excellent after long-term follow-up

2010-09-22
OAK BROOK, Ill. – September 21, 2010 – Researchers from Italy have reported results from more than 10 years of follow-up showing that the placement of multiple endoscopic stents for the treatment of postoperative biliary strictures remains excellent with a low rate of stricture recurrence after this lengthy period of time. When strictures do recur, they can be safely and successfully retreated endoscopically. The study appears in the September issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal ...

Queen's University researchers locate impulse control center in brain

2010-09-22
Impulsive behaviour can be improved with training and the improvement is marked by specific brain changes, according to a new Queen's University study. A research team led by neuroscience PhD student Scott Hayton has pinpointed the area of the brain that controls impulsive behavior and the mechanisms that affect how impulsive behavior is learned. The findings could have a significant impact on the diagnosis and treatment of several disorders and addictions, including ADHD and alcoholism. "In the classroom, kids often blurt out answers before they raise their hand. ...

LAST 30 PRESS RELEASES:

Science briefing: An update on GLP-1 drugs for obesity

Lower doses of immunotherapy for skin cancer give better results

Why didn’t the senior citizen cross the road? Slower crossings may help people with reduced mobility

ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment

A sound defense: Noisy pupae puff away potential predators

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

[Press-News.org] Scientists identify a new target for Alzheimer's disease